Abstract
The invention relates to a use of an aurantiamide dipepetide derivative in the treatment or prevention of angiogenesis-related diseases. Accordingly, aurantiamide dipeptide derivatives can be used as angiogenesis inhibitor, whereby preventing or treating invasive and metastatic cancer and ocular neovascularization (particularly macular degeneration such as pathological neovascularization of age-related macular degeneration (AMD)).
| Translated title of the contribution | AURANTIAMIDE DIPEPTIDE DERIVATIVES FOR TREATMENT OR PREVENTION OF ANGIOGENESIS-RELATED DISEASES |
|---|---|
| Original language | Chinese (Traditional) |
| Patent number | I602563 |
| IPC | A61K 31/27(2006.01); A61K 31/404(2006.01); A61P 27/02(2006.01); A61P 35/00(2006.01) |
| State | Published - 21 10 2017 |
Bibliographical note
公開公告號: I602563Announcement ID: I602563
Fingerprint
Dive into the research topics of 'AURANTIAMIDE DIPEPTIDE DERIVATIVES FOR TREATMENT OR PREVENTION OF ANGIOGENESIS-RELATED DISEASES'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver